EPO Diabetic Retinopathy Data: Longitudinal Biomarker Associations

117 participants from the Australian LANDMark cohort provide data on systemic erythropoietin levels and diabetic retinopathy severity. The dataset includes longitudinal measurements from baseline and a four-year follow-up, correlated with the ETDRS Diabetic Retinopathy Severity Scale. Author Ingrid Wise published the data on figshare in May 2026.

Use Cases

• Analyze associations between systemic erythropoietin levels and diabetic retinopathy severity based on the ETDRS scale.
• Train models to predict diabetic retinopathy progression based on biomarker levels mentioned in the description.
• Conduct longitudinal analysis of biomarker potential using baseline and four-year follow-up data.

Strengths

• Longitudinal design with baseline and four-year follow-up data from 117 participants.
• Clinical relevance through correlation with the established ETDRS Diabetic Retinopathy Severity Scale.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

LANDMark study cohort in Australia.

Collection Method

Clinical cohort study examining correlations between systemic EPO levels and DR severity.

Time Range

Baseline and four-year follow-up.

Freshness

Last updated 2026-05-15 06:28:04; freshness should be verified.

Geography

Australia.